D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overview All 13F holders of TPTX Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 5; Since Q1 2021

Holdings of TPTX by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−121,286−100.0%	Sold out	Holders
Q1 2022	121,286	$3.26M	<0.1%	+17,130+16.4%	Added	Holders
Q4 2021	104,156	$4.97M	<0.1%	−5,262−4.8%	Reduced	Holders
Q3 2021	109,418	$7.27M	<0.1%	−19,601−15.2%	Reduced	Holders
Q2 2021	129,019	$10.1M	<0.1%	−126,910−49.6%	Reduced	Holders
Q1 2021	255,929	$24.2M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.